Press Release Cybin Receives UK MHRA Approval to Commence EMBRACE, A Multinational Pivotal Study Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder 17 July 2025
Press Release Elucid Names Richard E. Kuntz, MD, MSc and Shamiram Feinglass, MD, MPH Board Directors 17 July 2025
Press Release PureTech Founded Entity Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress 17 July 2025
Press Release Great Hill Partners Welcomes Seasoned Healthcare Executive Shannon Delage as Growth Partner 17 July 2025
Press Release Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy 17 July 2025
Press Release Roblox Continues to Advance Safety Innovations, Launching Age Estimation, Empowering Teens to Connect With People They Know and Trust, and Additional Features 17 July 2025
Press Release Seaport Therapeutics Announces First Patient Dosed in Phase 2b BUOY-1 Study of GlyphAllo™ (SPT-300) in Major Depressive Disorder (MDD), With or Without Anxious Distress 17 July 2025
